The Biopharmaceutical Market To Stick To CAGR Between 9.4%

Market Report Summary 

• Market – Biopharmaceutical Market 
• Market Value – US$ 278,232.9 Mn in 2021 
• Market CAGR Value – 9.4% in 2021 
• Market Forecast Year – 2020 to 2030 

Get Sample Copy of This Report ->  Click Here 

Read Full Press Release Below

According to a new market report published by Persistence Market Research “Global Market Study on Biopharmaceuticals: Asia to Witness Highest Growth by 2020”, the global biopharmaceuticals market was valued at US$ 162 Bn in 2014 and is expected to grow at a CAGR of 9.4% from 2014 to 2020, to reach an estimated value of US$ 278 Bn by 2020.

Biopharmaceuticals are medicinal drugs, produced by isolation of the medicinal products from biological sources such as from animals, plants, humans and microorganisms, using biotechnological techniques such as recombinant DNA technology.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/2827

Some of the major players in the Biopharmaceuticals market:

• Pfizer, Inc.
• F. Hoffmann-La Roche AG.
• Johnson & Johnson Services, Inc.
• Sanofi, Amgen Inc.
• AbbVie Inc.
• Merck & Co., Inc.
• Biogen Idec.
• Bayer AG.
• Eli Lilly and Company.
• Novartis AG GlaxoSmithKline Plc.
• Bristol-Myers Squibb Company.
• AstraZeneca PLC.
• Abbott Laboratories.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/2827  

They can also be produced using transgenic organisms, particularly animals and plants that have been genetically engineered to produce drugs. These drugs help in prevention and treatment of various diseases such as rheumatoid arthritis, psoriatic arthritis, psoriasis, cardiovascular disease, anemia arising from chemotherapy, chronic renal failure, cancer, and diabetes.

Globally, the biopharmaceuticals market is witnessing significant growth due to increasing prevalence of chronic diseases, rising aging population, technological advancements in biopharmaceuticals, and increasing R&D investments. In addition, the capability of biopharmaceuticals to approach a particular target with high efficacy helps in the treatment of various chronic diseases and disorders.

Biopharmaceuticals, such as monoclonal antibodies, hormones, cytokines, clotting factors, cell therapies, antisense drugs, recombinant insulin, and vaccines, have the potential to prevent, treat, and completely heal the diseases which are otherwise difficult to cure or have no available treatment. This, in turn, fuels growth of the biopharmaceuticals market.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/2827

However, factors such as high costs of biopharmaceuticals, the risk of side–effects, and availability of low-cost biosimilars are restraining the growth of the global market for biopharmaceuticals. The global biopharmaceuticals market was valued at US$ 162 Bn in 2014 and is expected to reach US$ 278 Bn by 2020 at a CAGR of 9.4% during the forecast period.

North America is the largest market for biopharmaceuticals. This is due to technological advancements in the region. The North America market for biopharmaceuticals was valued at US$ 64.7 Bn in 2014 and is expected to reach US$ 111.5 Bn by 2020 at a CAGR of 9.5% over the forecast period. In terms of type, monoclonal antibodies are the fastest growing segment. In terms of therapeutic application, oncology is the largest segment in the biopharmaceuticals market. Biopharmaceuticals have wide applications in the pharmaceutical industry.

One of the latest trends in the global biopharmaceuticals market is that of outsourcing, where biopharmaceutical companies are dependent on contract manufacturing organizations to produce a biopharmaceutical drug substance, which helps reducing investments for a new product launch.